IMGN Stock: A Voyage Through Immunogen, Inc.’s Finances

Immunogen, Inc. (IMGN) currently has a stock price of $15.28. The stock saw a sharp increase in the last trading session, hitting a high of $16.42 after opening at $15.71. The lowest recorded price for the day was $15.6051 before it closed at $16.11.

The stock market performance of Immunogen, Inc. has been very steady. Over the last year, the company’s stock hit its highest at $20.69 on 07/19/23, while the lowest price during the same time frame was $3.61, recorded on 03/23/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of IMGN Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Immunogen, Inc.’s current trading price is -26.15% away from its 52-week high, while its distance from the 52-week low is 323.86%. The stock’s price range for this period has remained between $3.61 and $20.69. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.93 million for the day, which was noticeably lower compared to the shares’ average daily volume of 4.7 million over the last three months.

Financial Performance and Market Capitalization

Immunogen, Inc. (IMGN) has experienced a quarterly decline of -7.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.07B and boasts a workforce of 277 employees.

Analysts’ Ratings For Immunogen, Inc.

As of right now, 11 analysts are rating Immunogen, Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 16.06, with a change in price of -3.23. Similarly, Immunogen, Inc. recorded 4,691,911 in trading volume during the last 100 days, posting a change of -17.19%.

IMGN Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IMGN stands at 0.20. Similarly, the long-term debt-to-equity ratio is also 0.17.

IMGN Stock Stochastic Average

As of today, the raw stochastic average of Immunogen, Inc. over the last 50 days is at 72.79%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 72.60%. Further, the company’s Stochastic %K and %D values for the last 20 days were 77.22% and 76.77%, respectively.

IMGN Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 208.06%.However, over the last six months, we can see a weaker performance of 5.16%. Over the last 30 days, the price of IMGN has fallen by 7.99%. And in the last five days, it has surged by 3.66%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts